Future Outlook: The Convergence of "Personalized Immunology" and AI-Predictive Maintenance within the Asthma and COPD Drugs Sector for 2026

added blog Health

2026-01-02 12:23:14 -

As we look toward 2026, the respiratory industry is preparing for the era of "Personalized Immunology." This involves using "blood-based biomarkers" and genetic sequencing to predict exactly how a patient will respond to a specific biologic or combination therapy before it is even prescribed. This "precision" approach will eliminate the "trial-and-error" period that currently characterizes...

0 Comments 0 Shares 142 Views 0 Reviews